This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meijer, B. C.
Right arrow Articles by Berrelkamp, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meijer, B. C.
Right arrow Articles by Berrelkamp, R. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 01 1997, 292-294, Vol 35, No. 1
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori

BC Meijer, JC Thijs, JH Kleibeuker, AA van Zwet and RJ Berrelkamp
Regional Public Health Laboratory, University Hospital, Groningen, The Netherlands.

Eight commercial enzyme-linked immunosorbent assays (ELISAs) were used to test sera taken from 102 patients in whom Helicobacter pylori infection status had been determined by means of biopsy culture, PCR, histology, and urease production and by 13C urea breath test. By those means, 61 patients had been found to be infected. Assays were compared by receiver operating characteristic analysis. Sensitivities ranged from 86 to 98%; specificities ranged from 83 to 98%. In a group consisting of the assays by Bio-Whittaker, Meddens Biotech, Orion (Pyloriset EIA G, new version), and Enteric Products, Inc. (HM Cap), differences in performance were not statistically significant. Sensitivities in this group ranged from 93 to 98%; specificities ranged from 95 to 98%. Assays from this group may be useful in addition to biopsy-based methods in diagnosing H. pylori infection.


This article has been cited by other articles:

  • Ye, W., Held, M., Lagergren, J., Engstrand, L., Blot, W. J., McLaughlin, J. K., Nyren, O. (2004). Helicobacter pylori Infection and Gastric Atrophy: Risk of Adenocarcinoma and Squamous-Cell Carcinoma of the Esophagus and Adenocarcinoma of the Gastric Cardia. JNCI J Natl Cancer Inst 96: 388-396 [Abstract] [Full Text]  
  • Obata, Y., Kikuchi, S., Miwa, H., Yagyu, K., Lin, Y., Ogihara, A. (2003). Diagnostic accuracy of serological kits for Helicobacter pylori infection with the same assay system but different antigens in a Japanese patient population. J Med Microbiol 52: 889-892 [Abstract] [Full Text]  
  • Yamagata, H., Kiyohara, Y., Aoyagi, K., Kato, I., Iwamoto, H., Nakayama, K., Shimizu, H., Tanizaki, Y., Arima, H., Shinohara, N., Kondo, H., Matsumoto, T., Fujishima, M. (2000). Impact of Helicobacter pylori Infection on Gastric Cancer Incidence in a General Japanese Population: The Hisayama Study. Arch Intern Med 160: 1962-1968 [Abstract] [Full Text]  
  • van der Ende, A., van der Hulst, R. W. M., Roorda, P., Tytgat, G. N. J., Dankert, J. (1999). Evaluation of Three Commercial Serological Tests with Different Methodologies To Assess Helicobacter pylori Infection. J. Clin. Microbiol. 37: 4150-4152 [Abstract] [Full Text]  
  • Stone, M. A (1999). New techniques in medicine: Non-invasive testing for Helicobacter pylori. Postgrad. Med. J. 75: 74-77 [Abstract] [Full Text]  
  • Laheij, R. J. F., Straatman, H., Jansen, J. B. M. J., Verbeek, A. L. M. (1998). Evaluation of Commercially Available Helicobacter pylori Serology Kits: a Review. J. Clin. Microbiol. 36: 2803-2809 [Full Text]  
  • Oksanen, A., Veijola, L., Sipponen, P., Schauman, K.-O., Rautelin, H. (1998). Evaluation of Pyloriset Screen, a Rapid Whole-Blood Diagnostic Test for Helicobacter pylori Infection. J. Clin. Microbiol. 36: 955-957 [Abstract] [Full Text]